• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硅酞菁(Pc 4)光动力疗法是一种治疗皮肤肿瘤的安全方法:一项1期临床试验的结果

Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial.

作者信息

Baron Elma D, Malbasa Christi L, Santo-Domingo Diana, Fu Pingfu, Miller Janine D, Hanneman Kaija K, Hsia Andrew H, Oleinick Nancy L, Colussi Valdir C, Cooper Kevin D

机构信息

Department of Dermatology, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, Ohio 44106, USA.

出版信息

Lasers Surg Med. 2010 Dec;42(10):728-35. doi: 10.1002/lsm.20984.

DOI:10.1002/lsm.20984
PMID:21246576
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3149858/
Abstract

BACKGROUND

Photodynamic therapy (PDT) is a non-invasive treatment for non-melanoma skin cancer. However, PDT systems currently used clinically have limitations such as pain and superficial tissue penetration. The silicon phthalocyanine Pc 4 is a second-generation photosensitizer with peak absorption in the far red at 675 nm.

OBJECTIVE

To assess the safety and tolerability of topically applied Pc 4 followed by red light (Pc 4-PDT) in treating cutaneous neoplasms.

STUDY DESIGN/MATERIALS AND METHODS: Forty three adults with a diagnosis of neoplasms including actinic keratoses, Bowen's disease, squamous cell carcinoma, basal cell carcinoma, or mycosis fungoides were treated with a single administration of Pc 4-PDT and followed for 14 days. The study utilized a light and Pc 4 dose escalation design in sequential groups of three subjects each.

RESULTS

Pc 4-PDT was well tolerated with no significant local toxicity or increased photosensitivity. It has promising biologic effects, particularly in mycosis fungoides where 14 of 35 subjects demonstrated a clinical response, which correlates with Pc 4-PDT-induced apoptosis, as measured by increased active caspase-3 in the treated skin lesions.

CONCLUSIONS

Pc 4-PDT is a safe and tolerable treatment modality that effectively triggers apoptosis in cutaneous neoplasms such as mycosis fungoides.

摘要

背景

光动力疗法(PDT)是一种用于治疗非黑色素瘤皮肤癌的非侵入性疗法。然而,目前临床上使用的PDT系统存在诸如疼痛和组织穿透浅等局限性。硅酞菁Pc 4是一种第二代光敏剂,在675nm的远红光处有峰值吸收。

目的

评估局部应用Pc 4后再进行红光照射(Pc 4-PDT)治疗皮肤肿瘤的安全性和耐受性。

研究设计/材料与方法:43名被诊断患有包括光化性角化病、鲍恩病、鳞状细胞癌、基底细胞癌或蕈样肉芽肿在内的肿瘤的成年人接受了单次Pc 4-PDT治疗,并随访14天。该研究采用了光和Pc 4剂量递增设计,每组三名受试者,依次进行。

结果

Pc 4-PDT耐受性良好,无明显局部毒性或光敏性增加。它具有有前景的生物学效应,特别是在蕈样肉芽肿中,35名受试者中有14名表现出临床反应,这与Pc 4-PDT诱导的细胞凋亡相关,通过治疗的皮肤病变中活性半胱天冬酶-3的增加来衡量。

结论

Pc 4-PDT是一种安全且耐受性良好的治疗方式,可有效触发皮肤肿瘤如蕈样肉芽肿中的细胞凋亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0602/3149858/a1f920bad5fb/nihms-314763-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0602/3149858/c0262c16f599/nihms-314763-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0602/3149858/e4718980a531/nihms-314763-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0602/3149858/18bbb51ade6a/nihms-314763-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0602/3149858/a1f920bad5fb/nihms-314763-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0602/3149858/c0262c16f599/nihms-314763-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0602/3149858/e4718980a531/nihms-314763-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0602/3149858/18bbb51ade6a/nihms-314763-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0602/3149858/a1f920bad5fb/nihms-314763-f0004.jpg

相似文献

1
Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial.硅酞菁(Pc 4)光动力疗法是一种治疗皮肤肿瘤的安全方法:一项1期临床试验的结果
Lasers Surg Med. 2010 Dec;42(10):728-35. doi: 10.1002/lsm.20984.
2
Phthalocyanine photodynamic therapy: disparate effects of pharmacologic inhibitors on cutaneous photosensitivity and on tumor regression.酞菁光动力疗法:药理抑制剂对皮肤光敏性和肿瘤消退的不同影响。
Photochem Photobiol. 1997 May;65(5):895-901. doi: 10.1111/j.1751-1097.1997.tb01940.x.
3
Immunosuppressive effects of silicon phthalocyanine photodynamic therapy.硅酞菁光动力疗法的免疫抑制作用
Photochem Photobiol. 1999 Jul;70(1):72-7.
4
Photodynamic therapy with the phthalocyanine photosensitizer Pc 4 of SW480 human colon cancer xenografts in athymic mice.在无胸腺小鼠中,用酞菁光敏剂Pc 4对SW480人结肠癌异种移植瘤进行光动力治疗。
Clin Cancer Res. 2000 May;6(5):2021-7.
5
Recombinant human tumor necrosis factor alpha does not potentiate cell killing after photodynamic therapy with a silicon phthalocyanine in A431 human epidermoid carcinoma cells.重组人肿瘤坏死因子α在A431人表皮样癌细胞中与硅酞菁进行光动力治疗后不会增强细胞杀伤作用。
Int J Oncol. 2001 Feb;18(2):411-5. doi: 10.3892/ijo.18.2.411.
6
Monitoring Pc 4 photodynamic therapy in clinical trials of cutaneous T-cell lymphoma using noninvasive spectroscopy.在皮肤T细胞淋巴瘤临床试验中使用无创光谱法监测Pc 4光动力疗法。
J Biomed Opt. 2008 May-Jun;13(3):030507. doi: 10.1117/1.2939068.
7
Optimization of a nanomedicine-based silicon phthalocyanine 4 photodynamic therapy (Pc 4-PDT) strategy for targeted treatment of EGFR-overexpressing cancers.基于纳米药物的硅酞菁4光动力疗法(Pc 4-PDT)治疗表皮生长因子受体(EGFR)过表达癌症的靶向治疗策略优化
Mol Pharm. 2012 Aug 6;9(8):2331-8. doi: 10.1021/mp300256e. Epub 2012 Jul 19.
8
Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma.紫光联合外用 6-氨基乙酰丙酸光动力疗法治疗光化性角化病、鲍恩病和基底细胞癌。
J Eur Acad Dermatol Venereol. 2001 Nov;15(6):550-4. doi: 10.1046/j.1468-3083.2001.00333.x.
9
Apoptosis is an early event during phthalocyanine photodynamic therapy-induced ablation of chemically induced squamous papillomas in mouse skin.细胞凋亡是酞菁光动力疗法诱导小鼠皮肤化学诱导性鳞状乳头瘤消融过程中的早期事件。
Photochem Photobiol. 1996 Apr;63(4):547-52. doi: 10.1111/j.1751-1097.1996.tb03082.x.
10
Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: the case experience with preclinical mechanistic and early clinical-translational studies.使用酞菁光敏剂Pc 4进行光动力疗法:临床前机制研究和早期临床转化研究的病例经验
Toxicol Appl Pharmacol. 2007 Nov 1;224(3):290-9. doi: 10.1016/j.taap.2007.01.025. Epub 2007 Feb 15.

引用本文的文献

1
A new water-soluble silicon phthalocyanine that catalyzes the photodegradation of pollutant dyes.一种能催化污染物染料光降解的新型水溶性硅酞菁。
Turk J Chem. 2024 Dec 21;49(1):118-132. doi: 10.55730/1300-0527.3715. eCollection 2025.
2
Photodynamic Therapy: Past, Current, and Future.光动力疗法:过去、现在和未来。
Int J Mol Sci. 2024 Oct 21;25(20):11325. doi: 10.3390/ijms252011325.
3
Photodynamic therapy for cancer: mechanisms, photosensitizers, nanocarriers, and clinical studies.癌症的光动力疗法:作用机制、光敏剂、纳米载体及临床研究。
MedComm (2020). 2024 Jun 22;5(7):e603. doi: 10.1002/mco2.603. eCollection 2024 Jul.
4
Theranostics with photodynamic therapy for personalized medicine: to see and to treat.光动力疗法的治疗诊断学用于个性化医疗:既能诊断又能治疗。
Theranostics. 2023 Oct 9;13(15):5501-5544. doi: 10.7150/thno.87363. eCollection 2023.
5
Photodynamic therapy, priming and optical imaging: Potential co-conspirators in treatment design and optimization - a Thomas Dougherty Award for Excellence in PDT paper.光动力疗法、预处理与光学成像:治疗设计与优化中的潜在协同因素——一篇荣获托马斯·多尔蒂光动力疗法卓越奖的论文
J Porphyr Phthalocyanines. 2020 Nov-Dec;24(11n12):1320-1360. doi: 10.1142/s1088424620300098.
6
An Update on Recent Advances of Photodynamic Therapy for Primary Cutaneous Lymphomas.原发性皮肤淋巴瘤光动力治疗的最新进展综述
Pharmaceutics. 2023 Apr 24;15(5):1328. doi: 10.3390/pharmaceutics15051328.
7
The chemical basis of cytotoxicity of silicon-phthalocyanine-based near infrared photoimmunotherapy (NIR-PIT) and its implications for treatment monitoring.硅酞菁类近红外光免疫治疗(NIR-PIT)的细胞毒性的化学基础及其对治疗监测的意义。
Curr Opin Chem Biol. 2023 Jun;74:102289. doi: 10.1016/j.cbpa.2023.102289. Epub 2023 Mar 24.
8
Advances in Liposome-Encapsulated Phthalocyanines for Photodynamic Therapy.用于光动力疗法的脂质体包裹酞菁的研究进展
Life (Basel). 2023 Jan 21;13(2):305. doi: 10.3390/life13020305.
9
Impact of mono- and di-β-galactose moieties in / anticancer efficacy of pyropheophorbide-carbohydrate conjugates by photodynamic therapy.焦脱镁叶绿酸-碳水化合物缀合物中单-和二-β-半乳糖部分对光动力疗法抗癌疗效的影响。
Eur J Med Chem Rep. 2022 Aug;5. doi: 10.1016/j.ejmcr.2022.100047. Epub 2022 Apr 18.
10
Development of Biotechnological Photosensitizers for Photodynamic Therapy: Cancer Research and Treatment-From Benchtop to Clinical Practice.生物技术光动力治疗光敏剂的开发:癌症研究与治疗——从实验台到临床实践。
Molecules. 2022 Oct 13;27(20):6848. doi: 10.3390/molecules27206848.

本文引用的文献

1
Enhanced photodynamic efficacy towards melanoma cells by encapsulation of Pc4 in silica nanoparticles.通过将Pc4封装在二氧化硅纳米颗粒中来增强对黑色素瘤细胞的光动力疗效。
Toxicol Appl Pharmacol. 2009 Dec 1;241(2):163-72. doi: 10.1016/j.taap.2009.08.010. Epub 2009 Aug 18.
2
Topical photodynamic therapy with porphyrin precursors--assessment of treatment-associated pain in a retrospective study.使用卟啉前体的局部光动力疗法——一项回顾性研究中与治疗相关疼痛的评估
Photochem Photobiol Sci. 2009 Aug;8(8):1111-6. doi: 10.1039/b823378k. Epub 2009 Jun 10.
3
Collaborative development of a sun protection factor test method: a proposed European Standard. COLIPA Task Force 'Sun Protection Measurement', Europe.合作开发防晒因子测试方法:拟议的欧洲标准。COLI-PA 工作组“防晒测量”,欧洲。
Int J Cosmet Sci. 1996 Oct;18(5):203-18. doi: 10.1111/j.1467-2494.1996.tb00151.x.
4
Apoptosis mechanisms related to the increased sensitivity of Jurkat T-cells vs A431 epidermoid cells to photodynamic therapy with the phthalocyanine Pc 4.与Jurkat T细胞相较于A431表皮样细胞对酞菁Pc 4光动力疗法敏感性增加相关的凋亡机制
Photochem Photobiol. 2008 Mar-Apr;84(2):407-14. doi: 10.1111/j.1751-1097.2007.00278.x. Epub 2008 Jan 23.
5
Molecular effectors of multiple cell death pathways initiated by photodynamic therapy.光动力疗法引发的多种细胞死亡途径的分子效应器。
Biochim Biophys Acta. 2007 Sep;1776(1):86-107. doi: 10.1016/j.bbcan.2007.07.001. Epub 2007 Jul 6.
6
Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005.非黑色素瘤皮肤癌光动力治疗应用指南:国际共识。国际皮肤光动力治疗学会,2005年。
J Am Acad Dermatol. 2007 Jan;56(1):125-43. doi: 10.1016/j.jaad.2006.06.006.
7
Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study.光化性角化病患者局部应用氨基乙酰丙酸光动力疗法与冷冻疗法的个体内左右对比:一项多中心随机对照研究
Br J Dermatol. 2006 Nov;155(5):1029-36. doi: 10.1111/j.1365-2133.2006.07470.x.
8
Photodynamic therapy with methylaminolevulinate as a valuable treatment option for unilesional cutaneous T-cell lymphoma.以甲基氨基酮戊酸进行光动力疗法是单病灶皮肤T细胞淋巴瘤一种有价值的治疗选择。
Photodermatol Photoimmunol Photomed. 2006 Oct;22(5):254-8. doi: 10.1111/j.1600-0781.2006.00246.x.
9
Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy.采用补骨脂素加紫外线A光单药疗法实现完全缓解的早期皮肤T细胞淋巴瘤患者的长期随访
Arch Dermatol. 2005 Mar;141(3):305-11. doi: 10.1001/archderm.141.3.305.
10
WHO-EORTC classification for cutaneous lymphomas.世界卫生组织-欧洲癌症研究与治疗组织皮肤淋巴瘤分类
Blood. 2005 May 15;105(10):3768-85. doi: 10.1182/blood-2004-09-3502. Epub 2005 Feb 3.